AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and
New platform brings four of the industry's most recognized direct-to-consumer brands together to serve the cash-pay obstructive sleep apnea (OSA) market across North AmericaNEW YORK, Aug. 17, 2026 /PRNewswire/ --
CONSHOHOCKEN, Pa., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from the AdaptHealth Corp. (NASDAQ:AHCO) data breach.
AdaptHealth Corp. reported second quarter 2026 revenue of $740.3 million against consensus of roughly $847 million to $849 million, and a GAAP loss of $0.99 per share against expectations of approximately $0.15. Shares
NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) -- AdaptHealth Corp. (NASDAQ:AHCO) shareholders watched as much as 26% of their investment disappear after the Company's Q2 2026 results showed a GAAP loss of $0.99 per
Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of AdaptHealth Corp. ("AdaptHealth" or "the
AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and
AdaptHealth Corp. (NASDAQ:AHCO) shares fell as much as 26% after Q2 revenue of $740.3 million and a $0.99 GAAP loss missed expectations, alongside a $144.2 million goodwill impairment. Levi & Korsinsky is
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of AdaptHealth Corp. ("AdaptHealth" or the
On May 5, 2026, AdaptHealth raised its full-year 2026 revenue guidance to $3.45 billion to $3.52 billion. Weeks later, the Company reset that guidance to approximately $2.85 billion to $2.89 billion -- and the stock
Law Offices of Howard G. Smith announces an investigation on behalf of AdaptHealth Corp. ("AdaptHealth" or the "Company") (NASDAQ: AHCO) investors concerning the Company’s possible violations of federal
